1024210

Alexion Pharmaceuticals, Inc. — FEI 3006031727

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 3, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Haven, CT (United States)

Additional Details

Sponsor, Contract Research Organization